ロード中...
Efficacy and Safety of an Anti-nerve Growth Factor Antibody (Frunevetmab) for the Treatment of Degenerative Joint Disease-Associated Chronic Pain in Cats: A Multisite Pilot Field Study
Background: Pain management for cats with degenerative joint disease (DJD) remains a critical unmet need. Recent work has shown promise for a feline-specific anti-nerve growth factor monoclonal antibody (frunevetmab) to deliver safe and effective pain management. Our objectives were to evaluate the...
保存先:
| 出版年: | Front Vet Sci |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8195238/ https://ncbi.nlm.nih.gov/pubmed/34124212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fvets.2021.610028 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|